Electromagnetically induced transparency on a single artificial atom

We present experimental observation of electromagnetically induced transparency (EIT) on a single macroscopic artificial “atom” (superconducting quantum system) coupled to open 1D space of a transmission line. Unlike in an optical media with many atoms, the single-atom EIT in 1D space is revealed in suppression of reflection of electromagnetic waves, rather than absorption. The observed almost 100% modulation of the reflection and transmission of propagating microwaves demonstrates full controllability of individual artificial atoms and a possibility to manipulate the atomic states. The system can be used as a switchable mirror of microwaves and opens a good perspective for its applications in photonic quantum information processing and other fields

Resonance fluorescence of a single artificial atom

An atom in open space can be detected by means of resonant absorption and reemission of electromagnetic waves, known as resonance fluorescence, which is a fundamental phenomenon of quantum optics. We report on the observation of scattering of propagating waves by a single artificial atom. The behavior of the artificial atom, a superconducting macroscopic two-level system, is in a quantitative agreement with the predictions of quantum optics for a pointlike scatterer interacting with the electromagnetic field in one-dimensional open space. The strong atom-field interaction as revealed in a high degree of extinction of propagating waves will allow applications of controllable artificial atoms in quantum optics and photonics

Evaluation of silicon photomultipliers for dual-mirror Small-Sized Telescopes of Cherenkov Telescope Array

All camera designs for Small-Sized telescopes (SSTs) proposed for the Cherenkov Telescope Array (CTA) utilize silicon photomultipliers (SiPM) as their baseline photon sensor technology. The dual-mirror SST (SST-2M) has a smaller plate scale (i.e. image size) than the single-mirror SST, allowing it to employ 2,000 square SiPMs with pixel sizes of approximately 6 mm, close to the mainstream SiPM sizes.In CTA, the night sky background level of typically ~25 Mcounts/s/pixel ( > 100 Mcounts/s/pixel at maximum) places severe constraints on the trigger capability due to accidental coincidence on neighboring pixels. In order to suppress such events, it is necessary to reduce optical crosstalk, a mechanism whereby a single optical photon can produce multiple avalanches in the SiPM, while keeping good photon detection efficiency. These are, in general, contradicting requirements.In this manuscript, we report on characterization of a variety of SiPM technologies for SST-2M cameras and compare results obtained at different participating institutions. We assess the harmonization of results and discuss the likely performance that will be achieved for the first production cameras

Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms.

BACKGROUND: Intracranial aneurysms (IAs), abdominal aortic aneurysms (AAAs), and thoracic aortic aneurysms (TAAs) all have a familial predisposition. Given that aneurysm types are known to co-occur, we hypothesized that there may be shared genetic risk factors for IAs, AAAs, and TAAs. METHODS AND RESULTS: We performed a mega-analysis of 1000 Genomes Project-imputed genome-wide association study (GWAS) data of 4 previously published aneurysm cohorts: 2 IA cohorts (in total 1516 cases, 4305 controls), 1 AAA cohort (818 cases, 3004 controls), and 1 TAA cohort (760 cases, 2212 controls), and observed associations of 4 known IA, AAA, and/or TAA risk loci (9p21, 18q11, 15q21, and 2q33) with consistent effect directions in all 4 cohorts. We calculated polygenic scores based on IA-, AAA-, and TAA-associated SNPs and tested these scores for association to case-control status in the other aneurysm cohorts; this revealed no shared polygenic effects. Similarly, linkage disequilibrium-score regression analyses did not show significant correlations between any pair of aneurysm subtypes. Last, we evaluated the evidence for 14 previously published aneurysm risk single-nucleotide polymorphisms through collaboration in extended aneurysm cohorts, with a total of 6548 cases and 16 843 controls (IA) and 4391 cases and 37 904 controls (AAA), and found nominally significant associations for IA risk locus 18q11 near RBBP8 to AAA (odds ratio [OR]=1.11; P=4.1×10(-5)) and for TAA risk locus 15q21 near FBN1 to AAA (OR=1.07; P=1.1×10(-3)). CONCLUSIONS: Although there was no evidence for polygenic overlap between IAs, AAAs, and TAAs, we found nominally significant effects of two established risk loci for IAs and TAAs in AAAs. These two loci will require further replication

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study

Importance: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. Objective: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. Data Sources: Genomewide association studies (GWAS) published up to January 15, 2015. Study Selection: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. Data Extraction and Synthesis: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. Main Outcomes and Measures: Odds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. Results: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]). Conclusions and Relevance: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases